Ixekizumab: Difference between revisions
From IDWiki
(Created page with "* Used for moderate to severe plaque psoriasis * IL-17 inhibitor * Risks include pneumonia and superficial fungal infections Category:Medications") |
(No difference)
|
Revision as of 19:28, 12 February 2022
- Used for moderate to severe plaque psoriasis
- IL-17 inhibitor
- Risks include pneumonia and superficial fungal infections
